Document Detail

Mitral valve disease: if the mitral valve is not reparable/failed repair, is bioprosthesis suitable for replacement?
MedLine Citation:
PMID:  19056294     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: The durability of mitral bioprostheses has long been known to be inferior to aortic bioprostheses. Mitral valve reconstruction/repair is currently recommended for most mitral valve procedures. The choice of prostheses for non-reparable or failed mitral valve repairs has not been specified or given appropriate attention within the literature. The objective of this study is to address the role of bioprostheses in the specific subset of non-reparable or failed repair patients by using the knowledge of the general durability of mitral porcine bioprostheses, inclusive of the Carpentier-Edwards mitral porcine bioprosthesis. METHODS: The CE-SAV was implanted in 1135 patients (1175 operations) for mitral valve replacement (MVR) from 1982 to 2000. The mean age was 65.0+/-12.1 years (range 13-86 years). The mean follow-up was 6.4+/-4.5 years, 7555.9 patient-years and 98.3% complete. The evaluation considered freedom from structural valve deterioration (SVD) and freedom from composites of complications, as well as risk assessment. RESULTS: For the 51-60 year age group, the actual and actuarial freedom from SVD was, at 18 years, 56.0+/-4.1% and 14.7+/-5.8%; for the 61-70 year age group was, at 18 years, 69.6+/-2.6% and 26.5+/-5.9%, respectively. For the >70 group, at 15 years was 92.2+/-2.0% and 69.0+/-9.7%, respectively. There were a total of 256 SVD events with 31 fatalities and 226 reoperations with 10 fatalities (4.42%). The predictors of SVD were age (hazard ratio [HR] 0.98, p=0.0002), concomitant CAB (HR 0.66, p=0.020) and valve size (HR 1.08, p=0.034). The overall actual freedom, at 15-18 years, for >70 age group was, for valve-related reoperation, 94.3+/-1.5%; and for valve-related mortality was 87.8+/-2.3%. CONCLUSIONS: The CE-SAV mitral porcine bioprosthesis cannot be recommended as representative of prosthesis-type of choice for non-reparable or failed repair of native mitral valves for ages </=70 years. The CE-SAV mitral porcine bioprosthesis is satisfactory for implantation >70 years of age. The clinical performance of the CE-SAV is similar to other mitral bioprostheses.
William Robert Eric Jamieson; Virginia M Gudas; Lawrence H Burr; Michael T Janusz; Guy J Fradet; Hilton Ling; Eva Germann; Samuel V Lichtenstein
Related Documents :
8087264 - Comparative phonocardiographic, echocardiographic and doppler echocardiographic evaluat...
2781954 - Fluoroscopic differentiation between leaflet escape (le) and valve thrombosis (vt) of t...
22064974 - Concordance rates of doppler ultrasound and ct angiography in the grading of carotid ar...
14982274 - Nanobacteria-caused mitral valve calciphylaxis in a man with diabetic renal failure.
6940554 - Fatal epistaxis from an aneurysm of the intracranial internal carotid artery.
9564934 - Temporary luminal arteriotomy seal for bypass grafting.
Publication Detail:
Type:  Journal Article; Multicenter Study; Review     Date:  2008-12-03
Journal Detail:
Title:  European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery     Volume:  35     ISSN:  1873-734X     ISO Abbreviation:  Eur J Cardiothorac Surg     Publication Date:  2009 Jan 
Date Detail:
Created Date:  2008-12-22     Completed Date:  2009-11-04     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8804069     Medline TA:  Eur J Cardiothorac Surg     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  104-10     Citation Subset:  IM    
University of British Columbia, Vancouver, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Age Distribution
Aged, 80 and over
Epidemiologic Methods
Heart Valve Diseases / surgery*
Heart Valve Prosthesis*
Heart Valve Prosthesis Implantation / methods
Middle Aged
Mitral Valve / surgery*
Prosthesis Failure
Reoperation / methods
Treatment Failure
Young Adult

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Evaluation of skeletal and surgical factors related to relapse of mandibular setback surgery using t...
Next Document:  Current and future aggressive peripheral T-cell lymphoma treatment paradigms, biological features an...